Simultaneous determination of spironolactone and its metabolites in human plasma

被引:36
作者
Jankowski, A
SkorekJankowska, A
Lamparczyk, H
机构
关键词
canrenone; human plasma; spironolactone; 7; alpha-thiomethyl-spironolactone; UV-HPLC detection;
D O I
10.1016/S0731-7085(96)01767-0
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
This study describes a specific, precise, sensitive and accurate method for determination of unchanged spironolactone and its major active metabolites in human plasma. After one-step liquid-liquid extraction, analysis of the parent drug and its metabolites was performed in one chromatographic run, using a high performance liquid chromatography (HPLC) method with a programmed switchover of the UV wavelength. Spironolactone and 7 alpha-thiomethylspironolaclone were detected at 245 nm, while canrenone and internal standard were detected al 280 nm. The column used was an S5 ODS2 (500 mm x 4.6 mm i.d.). The mobile phase was a mixture of acetonitrile-aqueous orthophosphoric acid (pH 3.4). Chromatographic separations were performed at 5 degrees C. The standard curves were linear over the range 10-400 ng ml(-1) for spironolactone and 10-600 ng ml(-1) for 7 alpha-thiomethyl-spironolactone and canrenone. The precision and accuracy of the method were confirmed by relative standard deviations below 10%, for different concentrations, except for the concentration equal to the quantitation limit, where these parameters ranged from 12-15%, The recovery was above 80% for all investigated compounds and for the internal standard. The assay proved to be suitable for pharmacokinetic studies of spironolactone.
引用
收藏
页码:1359 / 1365
页数:7
相关论文
共 15 条
[1]   KINETICS OF CANRENONE AFTER SINGLE AND MULTIPLE DOSES OF SPIRONOLACTONE [J].
ABSHAGEN, U ;
BESENFELDER, E ;
ENDELE, R ;
KOCH, K ;
NEUBERT, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (04) :255-262
[2]  
DAHLOF CG, 1979, DRUG METAB DISPOS, V7, P103
[3]   SPIRONOLACTONE METABOLISM - STEADY-STATE SERUM LEVELS OF THE SULFUR-CONTAINING METABOLITES [J].
GARDINER, P ;
SCHRODE, K ;
QUINLAN, D ;
MARTIN, BK ;
BOREHAM, DR ;
ROGERS, MS ;
STUBBS, K ;
SMITH, M ;
KARIM, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (04) :342-347
[4]  
GOCHMAN N, 1962, J PHARMACOL EXP THER, V135, P312
[5]  
LOS LE, 1993, DRUG METAB DISPOS, V21, P1086
[6]  
MELANDER A, 1977, CLIN PHARMACOL THER, V22, P100
[7]  
MERKUS FW, 1989, CLIN PHARM, V2, P209
[8]   PHARMACOKINETICS OF SPIRONOLACTONE AFTER A SINGLE DOSE - EVALUATION OF THE TRUE CANRENONE SERUM CONCENTRATIONS DURING 24 HOURS [J].
MERKUS, FWHM ;
OVERDIEK, JWPM ;
CILISSEN, J ;
ZUIDEMA, J .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1983, 5 (02) :239-248
[9]  
NEURATH GB, 1979, J CHROMATOGR, V163, P230
[10]  
OVERDIEK HWP, 1987, DRUG METAB DRUG INTE, V5, P273